Detalhe da pesquisa
1.
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium.
Am J Epidemiol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775277
2.
Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma.
Histopathology
; 84(7): 1095-1110, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155475
3.
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
Cancer
; 129(5): 697-713, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572991
4.
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.
Br J Cancer
; 128(1): 137-147, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323878
5.
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
Br J Cancer
; 128(12): 2283-2294, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076566
6.
Profiling the immune landscape in mucinous ovarian carcinoma.
Gynecol Oncol
; 168: 23-31, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368129
7.
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
J Pathol
; 256(4): 388-401, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897700
8.
Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents.
Br J Cancer
; 125(2): 265-276, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33981016
9.
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
Mod Pathol
; 34(1): 194-206, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32724153
10.
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
Mod Pathol
; 32(12): 1834-1846, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31239549
11.
Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
Gynecol Oncol
; 150(3): 527-533, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30054102
12.
Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia.
Br J Haematol
; 174(4): 550-62, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27136044
13.
High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study.
J Am Acad Dermatol
; 74(6): 1144-1152.e6, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26830865
14.
Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
Clin Transplant
; 29(11): 978-90, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26278925
15.
Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
Int J Cancer
; 135(9): 2146-56, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24639369
16.
Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure.
Int J Cancer
; 133(4): 944-51, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23382012
17.
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
J Pathol Clin Res
; 9(3): 208-222, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948887
18.
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
medRxiv
; 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986741
19.
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Clin Cancer Res
; 28(24): 5383-5395, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222710
20.
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.
Virchows Arch
; 480(4): 855-871, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34782936